Table 2. Assessment of the quality of the eleven studies.
Aichinger 2012(9) | Blaivas 2001(10) | Breitkreutz 2010(11) | Flato 2015(13) | Chardoli 2012(12) | Salen 2001(16) | Salen 2005(4) | Tayal 2003(17) | Gaspari 2016(14) | Kim 2016(15) | Tomruk 2012(18) | |
---|---|---|---|---|---|---|---|---|---|---|---|
Representativeness of the exposed cohort | * | * | * | * | * | * | * | * | * | * | * |
Selection of the nonexposed cohort | * | * | * | * | * | * | * | * | * | * | * |
Ascertainment of exposure | * | * | * | * | * | * | * | * | * | * | * |
Demonstration that outcome of interest was not present at start of study | * | * | * | * | * | * | * | * | * | * | * |
Comparability of cohorts on the basis of the design or analysis | ** | - | - | ** | - | - | - | - | ** | ** | ** |
Assessement of outcome | * | * | * | * | * | * | * | * | * | * | * |
Was follow-up long enough for outcomes to occur | * | * | * | * | * | * | * | * | * | * | * |
Adequacy of follow up of cohort | * | * | * | * | * | * | * | * | * | * | * |
*: One star
**: Two stars.